Total Debt
—
Net Debt
-$170.4M
Inhibikase Therapeutics, Inc. currently has — in total debt. Net debt is -$170.4M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
IKT • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.00 | 0.17 | -0.17Net Cash | 0.17 | 0.0% |
| 2025-12-31 | 0.00 | 0.18 | -0.18Net Cash | 0.18 | 0.0% |
| 2025-09-30 | 0.00 | 0.08 | -0.08Net Cash | 0.08 | 0.0% |
| 2025-06-30 | 0.00 | 0.09 | -0.09Net Cash | 0.09 | 0.0% |
| 2025-03-31 | 0.00 | 0.09 | -0.09Net Cash | 0.09 | 0.1% |
| 2024-12-31 | 0.00 | 0.10 | -0.10Net Cash | 0.10 | 0.1% |
| 2024-09-30 | 0.00 | 0.00 | -0.00Net Cash | 0.00 | 5.0% |
| 2024-06-30 | 0.00 | 0.01 | -0.01Net Cash | 0.01 | 4.0% |
| 2024-03-31 | 0.00 | 0.01 | -0.01Net Cash | 0.01 | 4.4% |
| 2023-12-31 | 0.00 | 0.01 | -0.01Net Cash | 0.01 | 4.3% |
| 2023-09-30 | 0.00 | 0.02 | -0.02Net Cash | 0.02 | 1.5% |
| 2023-06-30 | 0.00 | 0.02 | -0.02Net Cash | 0.02 | 1.3% |
| 2023-03-31 | 0.00 | 0.03 | -0.03Net Cash | 0.03 | 1.2% |
| 2022-12-31 | 0.00 | 0.02 | -0.02Net Cash | 0.02 | 1.4% |
| 2022-09-30 | 0.00 | 0.03 | -0.03Net Cash | 0.03 | 1.3% |
| 2022-06-30 | 0.00 | 0.03 | -0.03Net Cash | 0.03 | 0.0% |
| 2022-03-31 | 0.00 | 0.04 | -0.04Net Cash | 0.04 | 0.0% |
| 2021-12-31 | 0.00 | 0.04 | -0.04Net Cash | 0.04 | 0.6% |
| 2021-09-30 | 0.00 | 0.04 | -0.04Net Cash | 0.05 | 0.5% |
| 2021-06-30 | 0.00 | 0.05 | -0.05Net Cash | 0.05 | 0.5% |
| 2021-03-31 | 0.00 | 0.01 | -0.01Net Cash | 0.01 | 10.5% |
| 2020-12-31 | 0.00 | 0.01 | -0.01Net Cash | 0.01 | 2.2% |
| 2020-09-30 | 0.00 | 0.00 | 0.00 | 0.00 | 49.0% |
| 2020-06-30 | 0.00 | 0.00 | 0.00 | 0.00 | 182.6% |
| 2020-03-31 | 0.00 | 0.00 | 0.00 | 0.00 | 1743.5% |
| 2019-12-31 | 0.00 | 0.00 | 0.00 | 0.00 | 977.1% |
| 2019-03-31 | 0.00 | 0.00 | -0.00Net Cash | 0.00 | — |
| 2018-12-31 | 0.00 | 0.00 | -0.00Net Cash | 0.00 | 8.2% |
| 2018-03-31 | 0.00 | 0.00 | 0.00 | 0.00 | 147.9% |
| 2017-12-31 | 0.00 | 0.00 | 0.00 | 0.00 | 161.3% |
| 2017-03-31 | 0.00 | 0.00 | -0.00Net Cash | 0.00 | — |